1. Home
  2. WEN vs NVAX Comparison

WEN vs NVAX Comparison

Compare WEN & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wendy's Company (The)

WEN

Wendy's Company (The)

HOLD

Current Price

$6.81

Market Cap

1.4B

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$8.62

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WEN
NVAX
Founded
1969
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
2000
1996

Fundamental Metrics

Financial Performance
Metric
WEN
NVAX
Price
$6.81
$8.62
Analyst Decision
Hold
Hold
Analyst Count
22
9
Target Price
$8.88
$11.33
AVG Volume (30 Days)
7.2M
3.4M
Earning Date
05-08-2026
05-07-2026
Dividend Yield
8.26%
N/A
EPS Growth
N/A
309.76
EPS
0.85
2.58
Revenue
$2,176,891,000.00
$1,123,479,000.00
Revenue This Year
$2.35
N/A
Revenue Next Year
$0.94
N/A
P/E Ratio
$7.99
$3.25
Revenue Growth
N/A
64.69
52 Week Low
$6.63
$5.80
52 Week High
$13.06
$11.85

Technical Indicators

Market Signals
Indicator
WEN
NVAX
Relative Strength Index (RSI) 41.88 47.42
Support Level $6.73 $8.09
Resistance Level $7.34 $9.05
Average True Range (ATR) 0.24 0.41
MACD 0.01 0.01
Stochastic Oscillator 29.51 59.71

Price Performance

Historical Comparison
WEN
NVAX

About WEN Wendy's Company (The)

The Wendy's Co is engaged in operating, developing, and franchising a system of distinctive quick-service restaurants serving high-quality food. The company operates through Wendy's U.S., Wendy's International, and Global Real Estate & Development. Wendy's U.S. and Wendy's International include the operation and franchising of restaurants and derive revenues from sales at company-operated restaurants, as well as royalties, franchise fees, and advertising fund collections from franchised restaurants. Global Real Estate & Development includes real estate activities for owned and leased sites that are leased or subleased to franchisees and includes the company's share of income from its Canadian restaurant real estate joint venture.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: